Short-acting GLP-1RAs, such as lixisenatide, maintain robust effects on gastric emptying, whereas long-acting agents, like liraglutide and semaglutide, exhibit reduced efficacy due to continuous receptor activation
Subgroup analyses by sex have not been prominently reported in published data, meaning sex-specific safety conclusions remain limited
Laviola L, Natalicchio A, Giorgino F (2007) The IGF-I signaling pathway
Plus, dosages may not be accurate due to factors like excess dilution, potentially compromising treatment effectiveness or safety
Certain Medical Conditions People with a history of conditions such as pancreatitis, severe gastrointestinal disorders, gallbladder disease, significant kidney or liver problems or certain endocrine conditions may require careful assessment before considering Retatrutide